Venn Life Sciences Holdings PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Venn Life Sciences Holdings PLC Wins Contracts for Phase IV Interaction Study and Multi-national Study; Opens Additional Office in UK
Venn Life Sciences Holdings PLC announced that it has signed two substantial contracts to provide a number of clinical trial management services across Europe. The first is with a top 10 global pharmaceutical company to conduct a Phase IV, drug-drug interaction study and the second is with a US Biotech company to manage a multi-national study. These two contracts, combined with other recent contract wins, will contribute approximately EUR 900,000 in additional revenue for the fiscal year 2013. The Company also announced that it has recently opened an additional office in the UK.
Latest Developments for Venn Life Sciences Holdings PLC
- Venn Life Sciences Holdings PLC announces acquisition of Belfast based CRO
- Venn Life Sciences Holdings PLC Announces Launch of Innovation Division and Co-Development Initiative
- Venn Life Sciences Holdings PLC Announces Senior Management Appointments
- Venn Life Sciences Holdings PLC Establishes Joint Venture in Russia
- Share this
- Digg this